Stage 3 Uterine Cancer - Five Year Survival

Survival rate measures the percentage of patients with a specific type of cancer who are still alive after a certain period of time. In this case, the survival rate is measured as five-year survival.

For most cancers, the survival rate is best when the cancer is found in an early stage. Early diagnosis, followed by the best treatment for that stage, can increase the chances for survival and can decrease post-treatment problems. Survival is usually lower when cancer is found at a later stage. Cancer survival rates indicate how many patients were still alive five years after diagnosis but are not adjusted for many factors which affect survival.

About the measure

This measure tracks the percentage of patients with stage 3 uterine cancer who were still alive five years after diagnosis or treatment for uterine cancer.

These numbers include all patients who were either diagnosed or treated for stage 3 uterine cancer at Northwestern Memorial sometime in 2003-2005. Patients may have been diagnosed somewhere else and treated here or diagnosed here and treated somewhere else.

In this case, a higher number is better.

Most Recent Available Data (Percent)
Northwestern Memorial 82
Teaching and Research Hospitals Comparison 52
Source:©Commission on Cancer, American College of Surgeons. NCDB Benchmark Reports, v1.1. Chicago, IL, 2002.
The content reproduced from the applications remains the full and exclusive copyrighted property of the American College of Surgeons. The American College of Surgeons is not responsible for any ancillary or derivative works based on the original Text, Tables, or Figures.